Grand Rapids, MI. – December 1st, 2021 – Genesis Innovation Group’s cultivate(MD) Capital Funds announces that one of their portfolio companies, Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, has raised $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird Capital, with significant […]
Lincoln, Neb., and Pleasanton, Calif. – November 30, 2021 – Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46 million in a Series C funding round. In addition to cultivate(MD) being a key investor in this Series C, Genesis Innovation Group also helped play
Company Begins IDE Study, Advancing Goal of Bringing Robotically Assisted Surgery to Any U.S. Hospital or Ambulatory Surgery Center
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery
HOLLAND, Mich., Jan. 13, 2020 PRNewswire — Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its participation in Virtual Incision Corporation’s raise of $20 million in Series B+ financing. Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot and the
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
Virtual Incision Announces $20 Million Financing Read More »
